These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20360013)

  • 1. A simple approach for assessing equilibrated Kt/V beta 2-M on a routine basis.
    Casino FG; Pedrini LA; Santoro A; Mandolfo S; David S; De Cristofaro V; Teatini U; Lomonte C; Lopez T
    Nephrol Dial Transplant; 2010 Sep; 25(9):3038-44. PubMed ID: 20360013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
    Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
    Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients.
    Okuno S; Ishimura E; Kohno K; Fujino-Katoh Y; Maeno Y; Yamakawa T; Inaba M; Nishizawa Y
    Nephrol Dial Transplant; 2009 Feb; 24(2):571-7. PubMed ID: 18799606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantifying dialysis efficiency for middle molecules in haemodialysis and in convective and mixed techniques].
    Casino FG; Lopez T
    G Ital Nefrol; 2008; 25(1):66-75. PubMed ID: 18264920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
    Fry AC; Singh DK; Chandna SM; Farrington K
    Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A circulating beta 2-microglobulin intermediate in hemodialysis patients.
    Uji Y; Motomiya Y; Ando Y
    Nephron Clin Pract; 2009; 111(3):c173-81. PubMed ID: 19194107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study.
    Cheung AK; Rocco MV; Yan G; Leypoldt JK; Levin NW; Greene T; Agodoa L; Bailey J; Beck GJ; Clark W; Levey AS; Ornt DB; Schulman G; Schwab S; Teehan B; Eknoyan G
    J Am Soc Nephrol; 2006 Feb; 17(2):546-55. PubMed ID: 16382021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of high-permeability haemodialysis against conventional haemodialysis in the treatment of uraemic pruritus.
    Chen ZJ; Cao G; Tang WX; Lv XY; Huang SM; Qin W; Ping F; Ye T
    Clin Exp Dermatol; 2009 Aug; 34(6):679-83. PubMed ID: 19175617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-2 microglobulin levels in hemodialysis patients.
    Mumtaz A; Anees M; Bilal M; Ibrahim M
    Saudi J Kidney Dis Transpl; 2010 Jul; 21(4):701-6. PubMed ID: 20587875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Middle molecules removal. Beyond beta2-microglobulin].
    Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
    Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of serum matrix metalloproteinase-3 in haemodialysis patients with dialysis-related amyloidosis.
    Naganuma T; Sugimura K; Uchida J; Tashiro K; Yoshimura R; Takemoto Y; Nakatani T
    Nephrology (Carlton); 2008 Apr; 13(2):104-8. PubMed ID: 18275497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.
    Panichi V; Rizza GM; Paoletti S; Bigazzi R; Aloisi M; Barsotti G; Rindi P; Donati G; Antonelli A; Panicucci E; Tripepi G; Tetta C; Palla R;
    Nephrol Dial Transplant; 2008 Jul; 23(7):2337-43. PubMed ID: 18305316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cystatin C and Beta-2-microglobulin kinetics in children on maintenance hemodialysis.
    Marsenic O; Wierenga A; Wilson DR; Anderson M; Shrivastava T; Simon GA; Beck AM; Swanson TJ; Studnicka K; Elberg D; Singh NS; Couloures K; Henry D; Turman MA
    Hemodial Int; 2013 Oct; 17 Suppl 1():S11-6. PubMed ID: 24134324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in beta2-microglobulin with super-flux versus high-flux dialysis membranes: results of a 6-week, randomized, double-blind, crossover trial.
    Pellicano R; Polkinghorne KR; Kerr PG
    Am J Kidney Dis; 2008 Jul; 52(1):93-101. PubMed ID: 18423807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
    Zehnder C; Gutzwiller JP; Renggli K
    Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uraemic itching: do polymethylmethacrylate dialysis membranes play a role?
    Aucella F; Vigilante M; Gesuete A; Maruccio G; Specchio A; Gesualdo L
    Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v8-12. PubMed ID: 17586845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of high-flux hemodialysis on renal anemia.
    Ayli D; Ayli M; Azak A; Yüksel C; Kosmaz GP; Atilgan G; Dede F; Abayli E; Camlibel M
    J Nephrol; 2004; 17(5):701-6. PubMed ID: 15593038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
    Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L
    Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A sad but forgotten truth: the story of slow-moving solutes in fast hemodialysis.
    Eloot S; Van Biesen W; Vanholder R
    Semin Dial; 2012; 25(5):505-9. PubMed ID: 22925227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard Kt/V thresholds to accurately predict single-pool Kt/V targets for children receiving thrice-weekly maintenance haemodialysis.
    Mammen C; Goldstein SL; Milner R; White CT
    Nephrol Dial Transplant; 2010 Sep; 25(9):3044-50. PubMed ID: 20348543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.